东曜药业股份有限公司（“东曜药业-B”，股票代码：01875）于2026年3月5日公告，披露截至2026年2月28日的股份变动月报。
报告期内公司普通股已发行股份总数由上月末的772,787,887股维持不变，期末依旧为772,787,887股，未出现新增发行、购回或注销行为，公司库藏股数量为0。注册股本无变化。
根据公司于2013年2月20日采纳的首次公开发售前购股权计划，本月末可行使的期权数量为7,632,600份，与上月持平。
公司确认已符合适用的公众持股量要求，并遵守香港联合交易所有限公司《上市规则》及相关法律规定。该月报由联席公司秘书吕颖一签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.